Kebele Elimination of Trachoma for Ocular Health

Description

The investigators propose a cluster-randomized clinical trial to determine whether an intensive, targeted azithromycin distribution strategy is effective for elimination of trachoma at the kebele level compared to the World Health Organization (WHO) recommendation of annual azithromycin distribution.

Conditions

Trachoma

Study Overview

Study Details

Study overview

The investigators propose a cluster-randomized clinical trial to determine whether an intensive, targeted azithromycin distribution strategy is effective for elimination of trachoma at the kebele level compared to the World Health Organization (WHO) recommendation of annual azithromycin distribution.

Kebele Elimination of Trachoma for Ocular Health

Kebele Elimination of Trachoma for Ocular Health

Condition
Trachoma
Intervention / Treatment

-

Contacts and Locations

San Francisco

UCSF Proctor Foundation, San Francisco, California, United States, 94143

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * All individuals in all communities will be eligible for annual mass azithromycin distribution per WHO guidelines.
  • * Those who do not consent.

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Francisco,

Tom M Lietman, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Hadley Burroughs, MSPH, STUDY_DIRECTOR, University of California, San Francisco

Study Record Dates

2028-03-01